Sugi Predict

Sugi Predict / Compounds / SCHEMBL864088

SCHEMBL864088

SCHEMBL864088

CCC(O)(c1ccccc1)C(F)(F)C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.43
▸ LMNA P02545 6/20 0.43
▸ MAPT P10636 6/20 0.43
▸ S1PR4 O95977 2/20 0.43
▸ S1PR1 P21453 2/20 0.43
▸ NPSR1 Q6W5P4 2/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ CYP2C19 P33261 1/20 0.40
▸ HIF1A Q16665 1/20 0.40
▸ CYP1A2 P05177 2/20 0.39
▸ HTT P42858 2/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ PTPN1 P18031 1/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ RIPK1 Q13546 1/20 0.38
▸ NR1H2 P55055 1/20 0.37
▸ NR1H3 Q13133 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12329628 0.80 ALDH1A1 (0.47) ALDH1A1LMNAMAPTS1PR4S1PR1
SCHEMBL16363123 0.80 ALDH1A1 (0.47) ALDH1A1LMNAMAPTS1PR4S1PR1
SCHEMBL4433627 0.80 CYP2C19 (0.44) ALDH1A1LMNASMN1; SMN2CYP2C19HIF1A
SCHEMBL4063599 0.75 CYP2C19 (0.44) ALDH1A1MAPTCYP2C19HIF1ACYP1A2
SCHEMBL29156731 0.74 CYP2C19 (0.40) ALDH1A1LMNASMN1; SMN2CYP2C19HIF1A
SCHEMBL27833618 0.74 CYP2C19 (0.42) ALDH1A1LMNAMAPTS1PR4S1PR1
SCHEMBL584028 0.74 CYP2C19 (0.47) ALDH1A1LMNAMAPTCYP2C19HIF1A
SCHEMBL7899580 0.74 CYP2C19 (0.47) ALDH1A1LMNAMAPTCYP2C19HIF1A
SCHEMBL5570579 0.74 CYP2C19 (0.47) ALDH1A1LMNAMAPTCYP2C19HIF1A
SCHEMBL27384297 0.74 THRB (0.52) ALDH1A1LMNAMAPTS1PR4S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8592540-B2 Fluorine-containing compound, fluorine-containing polymer compound, resist composition and patterning method using same CENTRAL GLASS COMPANY, LIMITED (JP) 2013-11-26 — — US disclosed
US-20120077126-A1 Fluorine-Containing Compound, Fluorine-Containing Polymer Compound, Resist Composition, Top Coat Composition And Pattern Formation Method CENTRAL GLASS COMPANY, LIMITED (JP) 2012-03-29 — — US disclosed
US-20110318542-A1 Fluorine-Containing Compound, Fluorine-Containing Polymer Compound, Resist Composition and Patterning Method Using Same CENTRAL GLASS COMPANY, LIMITED (JP) 2011-12-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120077126-A1 Fluorine-Containing Compound, Fluorine-Containing Polymer Compound, Resist Composition, Top Coat Composition And Pattern Formation Method FRG1, AFF2, FBXL19 ALDH1A1 4430/4885LMNA 1234/4885MAPT 836/4885
US-20110318542-A1 Fluorine-Containing Compound, Fluorine-Containing Polymer Compound, Resist Composition and Patterning Method Using Same FRG1, AFF2, AFF1 ALDH1A1 2738/4885LMNA 2479/4885MAPT 2258/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.